Skip to main content

Advertisement

Log in

Acromegalia ed ecografia: uno sguardo nel profondo

  • RASSEGNA
  • Published:
L'Endocrinologo Aims and scope

Sommario

La sempre più vasta disponibilità e il maggior potere diagnostico delle indagini ultrasonografiche nel rivelare i segni delle numerose comorbidità e complicanze dell’acromegalia, anche quando non ancora diagnosticata, possono contribuire a ridurre il frequente ritardo diagnostico. La cardiomiopatia acromegalica può essere precocemente rivelata dall’ecocardiogramma, come l’aterosclerosi, dallo studio dell’intima. La visceromegalia, il gozzo multinodulare, la rigidità dei parenchimi, steatosi epatica, colelitiasi, polipi della cistifellea, cisti renali, nefrolitiasi e ovaio policistico, sono alcune delle alterazioni evidenti all’ecografia. L’ecografia muscoloscheletrica e neuronale può evidenziare aumento dello spessore della cartilagine articolare, ridotta mineralizzazione ossea e l’aumento del diametro delle fibre nervose. La conoscenza di tali evidenze ecografiche anche da parte dei numerosi specialisti non endocrinologi potrebbe contribuire alla riduzione del ritardo diagnostico nell’acromegalia.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Bibliografia

  1. Giustina A, Barkan A, Beckers A et al. (2020) A consensus on the diagnosis and treatment of acromegaly comorbidities: an update. J Clin Endocrinol Metab 105(4):dgz096

    Article  PubMed  Google Scholar 

  2. Gadelha MR, Kasuki L, Lim DS, Fleseriu M (2019) Systemic complications of acromegaly and the impact of the current treatment landscape: an update. Endocr Rev 40(1):268–332

    Article  PubMed  Google Scholar 

  3. Gasperi M, Martino E, Manetti L et al. (2002) Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 25(3):240–245

    Article  CAS  PubMed  Google Scholar 

  4. Wolinski K, Czarnywojtek A, Ruchala M (2014) Risk of thyroid nodular disease and thyroid cancer in patients with acromegaly – meta-analysis and systematic review. PLoS ONE 9(2):e88787

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Dal J, Leisner MZ, Hermansen K et al. (2018) Cancer incidence in patients with acromegaly: a cohort study and meta-analysis of the literature. J Clin Endocrinol Metab 103(6):2182–2188

    Article  PubMed  Google Scholar 

  6. Dogansen SC, Salmaslioglu A, Yalin GY et al. (2019) Evaluation of the natural course of thyroid nodules in patients with acromegaly. Pituitary 22(1):29–36

    Article  CAS  PubMed  Google Scholar 

  7. Bankir M, Sumbul HE, Koc AS et al. (2019) Elastography detected solid organ stiffness increased in patients with acromegaly. Medicine 98(3):e14212

    Article  PubMed  PubMed Central  Google Scholar 

  8. Scacchi M, Andrioli M, Carzaniga C et al. (2009) Elastosonographic evaluation of thyroid nodules in acromegaly. Eur J Endocrinol 161(4):607–613

    Article  CAS  PubMed  Google Scholar 

  9. Lai NB, Garg D, Heaney AP et al. (2020) No benefit of dedicated thyroid nodule screening in patients with acromegaly. Endocr Pract 26(1):16–21

    Article  PubMed  Google Scholar 

  10. Bogazzi F, Manetti L, Bartalena L et al. (2002) Thyroid vascularity is increased in patients with active acromegaly. Clin Endocrinol 57(1):65–70

    Article  Google Scholar 

  11. Manetti L, Bogazzi F, Brogioni S et al. (2002) Submandibular salivary gland volume is increased in patients with acromegaly. Clin Endocrinol 57(1):97–100

    Article  Google Scholar 

  12. Parolin M, Dassie F, Martini C et al. (2018) Preclinical markers of atherosclerosis in acromegaly: a systematic review and meta-analysis. Pituitary 21(6):653–662

    Article  CAS  PubMed  Google Scholar 

  13. Akdeniz B, Gedik A, Turan O et al. (2012) Evaluation of left ventricular diastolic function according to new criteria and determinants in acromegaly. Int Heart J 53(5):299–305

    Article  PubMed  Google Scholar 

  14. Di Bello V, Bogazzi F, Di Cori A et al. (2006) Myocardial systolic strain abnormalities in patients with acromegaly: a prospective color Doppler imaging study. J Endocrinol Invest 29(6):544–550

    Article  PubMed  Google Scholar 

  15. Popielarz-Grygalewicz A, Gąsior JS, Konwicka A et al. (2018) Heart in acromegaly: the echocardiographic characteristics of patients diagnosed with acromegaly in various stages of the disease. Int J Endocrinol 2018:6935054

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sue M, Yoshihara A, Okubo Y et al. (2010) A case of juvenile acromegaly that was initially diagnosed as severe congestive heart failure from acromegaly-induced dilated cardiomyopathy. Int Med 49(19):2117–2121

    Article  CAS  Google Scholar 

  17. Ciulla MM, Epaminonda P, Paliotti R et al. (2004) Evaluation of cardiac structure by echoreflectivity analysis in acromegaly: effects of treatment. Eur J Endocrinol 151(2):179–186

    Article  CAS  PubMed  Google Scholar 

  18. Bogazzi F, Di Bello V, Palagi C et al. (2005) Improvement of intrinsic myocardial contractility and cardiac fibrosis degree in acromegalic patients treated with somatostatin analogues: a prospective study. Clin Endocrinol 62(5):590–596

    Article  CAS  Google Scholar 

  19. Colao A, Cuocolo A, Marzullo P et al. (2001) Is the acromegalic cardiomyopathy reversible? Effect of 5-year normalization of growth hormone and insulin-like growth factor I levels on cardiac performance. J Clin Endocrinol Metab 86(4):1551–1557

    CAS  PubMed  Google Scholar 

  20. Ciresi A, Guarnotta V, Campo D, Giordano C (2018) Hepatic steatosis index in acromegaly: correlation with insulin resistance regardless of the disease control. Int J Endocrinol 2018:5421961

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  21. Katznelson L, Laws ER Jr, Melmed S et al. (2014) Acromegaly: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 99(11):3933–3951

    Article  CAS  PubMed  Google Scholar 

  22. Montini M, Gianola D, Pagani MD et al. (1994) Cholelithiasis and acromegaly: therapeutic strategies. Clin Endocrinol 40(3):401–406

    Article  CAS  Google Scholar 

  23. Attanasio R, Mainolfi A, Grimaldi F et al. (2008) Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients. J Endocrinol Invest 31(8):704–710

    Article  CAS  PubMed  Google Scholar 

  24. Annamalai AK, Gayton EL, Webb A et al. (2011) Increased prevalence of gallbladder polyps in acromegaly. J Clin Endocrinol Metab 96(7):E1120–E1125

    Article  PubMed  Google Scholar 

  25. Sober AJ, Gorden P, Roth J, AvRuskin TW (1974) Visceromegaly in acromegaly. Evidence that clinical hepatomegaly or splenomegaly (but not sialomegaly) are manifestations of a second disease. Arch Intern Med 134(3):415–417

    Article  CAS  PubMed  Google Scholar 

  26. Yamamoto M, Matsumoto R, Fukuoka H et al. (2016) Prevalence of simple renal cysts in acromegaly. Int Med 55(13):1685–1690

    Article  Google Scholar 

  27. Auriemma RS, Galdiero M, De Martino MC et al. (2010) The kidney in acromegaly: renal structure and function in patients with acromegaly during active disease and 1 year after disease remission. Eur J Endocrinol 162(6):1035–1042

    Article  CAS  PubMed  Google Scholar 

  28. Sumbul HE, Koc AS (2019) Hypertension is common in patients with newly diagnosed acromegaly and is independently associated with Renal Resistive Index. High Blood Press Cardiovasc Prev 26(1):69–75

    Article  PubMed  Google Scholar 

  29. Kumar S, Yadav RN, Gupta P et al. (2015) Prostatic hyperplasia in acromegaly, a myth or reality: a case-control study. Eur J Endocrinol 172(2):97–106

    Article  CAS  PubMed  Google Scholar 

  30. Colao A, Marzullo P, Spiezia S et al. (2000) Effect of two years of growth hormone and insulin-like growth factor-I suppression on prostate diseases in acromegalic patients. J Clin Endocrinol Metab 85(10):3754–3761

    CAS  PubMed  Google Scholar 

  31. Corrêa LL, Lima GA, Paiva HB et al. (2009) Prostate cancer and acromegaly. Arq Bras Endocrinol Metabol 53(8):963–968

    Article  PubMed  Google Scholar 

  32. Grynberg M, Salenave S, Young J, Chanson P (2010) Female gonadal function before and after treatment of acromegaly. J Clin Endocrinol Metab 95(10):4518–4525

    Article  CAS  PubMed  Google Scholar 

  33. Kaltsas Androulakis GA II, Tziveriotis K et al. (2007) Polycystic ovaries and the polycystic ovary syndrome phenotype in women with active acromegaly. Clin Endocrinol 67(6):917–922

    Article  CAS  Google Scholar 

  34. Unluhizarci K, Kaltsas G, Kelestimur F (2012) Non polycystic ovary syndrome-related endocrine disorders associated with hirsutism. Eur J Clin Investig 42(1):86–94

    Article  CAS  Google Scholar 

  35. Cohen O, Schindel B, Homburg R (1998) Uterine leiomyomata – a feature of acromegaly. Hum Reprod 13(7):1945–1946

    Article  CAS  PubMed  Google Scholar 

  36. Colao A, Cannavò S, Marzullo P et al. (2003) Twelve months of treatment with octreotide-LAR reduces joint thickness in acromegaly. Eur J Endocrinol 148(1):31–38

    Article  CAS  PubMed  Google Scholar 

  37. Ozturk Gokce B, Gogus F, Bolayir B et al. (2020) The evaluation of the tendon and muscle changes of lower extremity in patients with acromegaly. Pituitary 23(4):338–346

    Article  PubMed  Google Scholar 

  38. Bolanowski M, Jedrzejuk D, Milewicz A, Arkowska A (2002) Quantitative ultrasound of the heel and some parameters of bone turnover in patients with acromegaly. Osteoporos Int 13(4):303–308

    Article  CAS  PubMed  Google Scholar 

  39. Bolanowski M, Pluskiewicz W, Adamczyk P, Daroszewski J (2006) Quantitative ultrasound at the hand phalanges in patients with acromegaly. Ultrasound Med Biol 32(2):191–195

    Article  PubMed  Google Scholar 

  40. Tagliafico A, Resmini E, Ferone D, Martinoli C (2011) Musculoskeletal complications of acromegaly: what radiologists should know about early manifestations. Radiol Med 116(5):781–792

    Article  CAS  PubMed  Google Scholar 

  41. Tagliafico A, Resmini E, Nizzo R et al. (2008) Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly. J Clin Endocrinol Metab 93(3):905–909

    Article  CAS  PubMed  Google Scholar 

  42. Prencipe N, Scarati M, Manetta T et al. (2020) Acromegaly and joint pain: is there something more? A cross-sectional study to evaluate rheumatic disorders in growth hormone secreting tumor patients. J Endocrinol Invest 43(11):1661–1667

    Article  CAS  PubMed  Google Scholar 

  43. Staples JR, Calfee R (2017) Cubital tunnel syndrome: current concepts. J Am Acad Orthop Surg 25(10):e215–e224

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Pietro Maffei.

Ethics declarations

Conflitto di interesse

Gli autori Matteo Parolin, Francesca Dassie, Roberto Vettor e Pietro Maffei dichiarano di non avere conflitti di interesse.

Consenso informato

Lo studio presentato in questo articolo non ha richiesto sperimentazione umana.

Studi sugli animali

Gli autori di questo articolo non hanno eseguito studi sugli animali.

Additional information

Proposto da Francesco Trimarchi.

Nota della casa editrice

Springer Nature rimane neutrale in riguardo alle rivendicazioni giurisdizionali nelle mappe pubblicate e nelle affiliazioni istituzionali.

Informazioni Supplementari

I link al materiale elettronico supplementare sono elencati qui sotto.

(DOC 30 kB)

(DOC 29 kB)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parolin, M., Dassie, F., Vettor, R. et al. Acromegalia ed ecografia: uno sguardo nel profondo. L'Endocrinologo 22, 179–186 (2021). https://doi.org/10.1007/s40619-021-00859-8

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40619-021-00859-8

Parole chiave

Navigation